Recombinant Human ARHGAP29 Protein, MYC/DDK-tagged, C13 and N15-labeled
Cat.No. : | ARHGAP29-194H |
Product Overview : | ARHGAP29 MS Standard C13 and N15-labeled recombinant protein (NP_004806) with a C-terminal MYC/DDK tag, was expressed in HEK293 cells. |
- Specification
- Gene Information
- Related Products
- Download
Description : | Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016] |
Source : | HEK293 |
Species : | Human |
Tag : | Myc/DDK |
Molecular Mass : | 142.1 kDa |
AA Sequence : | MIAHKQKKTKKKRAWASGQLSTDIT TSEMGLKSLSSNSIFDPDYIKELVN DIRKFSHMLLYLKEAIFSDCFKEVI HIRLEELLRVLKSIMNKHQNLNSVD LQNAAEMLTAKVKAVNFTEVNEENK NDLFQEVFSSIETLAFTFGNILTNF LMGDVGNDSLLRLPVSRETKSFENV SVESVDSSSEKGNFSPLELDNVLLK NTDSIELALSYAKTWSKYTKNIVSW VEKKLNLELESTRNMVKLAEATRTN IGIQEFMPLQSLFTNALLNDIESSH LLQQTIAALQANKFVQPLLGRKNEM EKQRKEIKELWKQEQNKMLEAENAL KKAKLLCMQRQDEYEKAKSSMFRAE EEHLSSSGGLAKNLNKQLEKKRRLE EEALQKVEEANELYKVCVTNVEERR NDLENTKREILAQLRTLVFQCDLTL KAVTVNLFHMQHLQAASLADSLQSL CDSAKLYDPGQEYSEFVKATNSTEE EKVDGNVNKHLNSSQPSGFGPANSL EDVVRLPDSSNKIEEDRCSNSADIT GPSFIRSWTFGMFSDSESTGGSSES RSLDSESISPGDFHRKLPRTPSSGT MSSADDLDEREPPSPSETGPNSLGT FKKTLMSKAALTHKFRKLRSPTKCR DCEGIVVFQGVECEECLLVCHRKCL ENLVIICGHQKLPGKIHLFGAEFTQ VAKKEPDGIPFILKICASEIENRAL CLQGIYRVCGNKIKTEKLCQALENG MHLVDISEFSSHDICDVLKLYLRQL PEPFILFRLYKEFIDLAKEIQHVNE EQETKKNSLEDKKWPNMCIEINRIL LKSKDLLRQLPASNFNSLHFLIVHL KRVVDHAEENKMNSKNLGVIFGPSL IRPRPTTAPITISSLAEYSNQARLV EFLITYSQKIFDGSLQPQDVMCSIG VVDQGCFPKPLLSPEERDIERSMKS LFFSSKEDIHTSESESKIFERATSF EESERKQNALGKCDACLSDKAQLLL DQEAESASQKIEDGKTPKPLSLKSD RSTNNVERHTPRTKIRPVSLPVDRL LLASPPNERNGRNMGNVNLDKFCKN PAFEGVNRKDAATTVCSKFNGFDQQ TLQKIQDKQYEQNSLTAKTTMIMPS ALQEKGVTTSLQISGDHSINATQPS KPYAEPVRSVREASERRSSDSYPLA PVRAPRTLQPQHWTTFYKPHAPIIS IRGNEEKPASPSAAVPPGTDHDPHG LVVKSMPDPDKASACPGQATGQPKE DSEELGLPDVNPMCQRPRLKRMQQF EDLEDEIPQFVTRTRPLEQKLISEE DLAANDILDYKDDDDKV |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Stability : | Stable for 3 months from receipt of products under proper storage and handling conditions. |
Storage : | Store at -80 centigrade. Avoid repeated freeze-thaw cycles. |
Concentration : | 50 μg/mL as determined by BCA |
Storage Buffer : | 100 mM glycine, 25 mM Tris-HCl, pH 7.3. |
Gene Name : | ARHGAP29 Rho GTPase activating protein 29 [ Homo sapiens (human) ] |
Official Symbol : | ARHGAP29 |
Synonyms : | ARHGAP29; Rho GTPase activating protein 29; rho GTPase-activating protein 29; PARG1; PTPL1-associated RhoGAP 1 (PARG1); PTPL1-associated RhoGAP protein 1; rho-type GTPase-activating protein 29; RP11-255E17.1; |
Gene ID : | 9411 |
mRNA Refseq : | NM_004815 |
Protein Refseq : | NP_004806 |
MIM : | 610496 |
UniProt ID : | Q52LW3 |
Products Types
◆ Recombinant Protein | ||
Arhgap29-246M | Recombinant Mouse Arhgap29 Protein, His-tagged | +Inquiry |
ARHGAP29-423R | Recombinant Rat ARHGAP29 Protein, His (Fc)-Avi-tagged | +Inquiry |
ARHGAP29-678M | Recombinant Mouse ARHGAP29 Protein, His (Fc)-Avi-tagged | +Inquiry |
ARHGAP29-2492H | Recombinant Human ARHGAP29 Protein, His (Fc)-Avi-tagged | +Inquiry |
Arhgap29-1686M | Recombinant Mouse Arhgap29 Protein, Myc/DDK-tagged | +Inquiry |
◆ Lysates | ||
ARHGAP29-8739HCL | Recombinant Human ARHGAP29 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (13)
Ask a questionCurrently, there is limited information regarding post-translational modifications of ARHGAP29. Investigating potential modifications like phosphorylation or ubiquitination could provide insights into its regulation and function.
At present, there are no known drugs or inhibitors specifically targeting ARHGAP29. Continued research into its function and potential therapeutic implications may uncover novel avenues for targeted interventions.
The involvement of ARHGAP29 in neuronal development or function has not yet been determined. Future studies focusing on the nervous system may shed light on its potential role in neurodevelopmental processes or neuronal signaling.
The specific interacting partners or regulators of ARHGAP29 have not been well-defined. Further research is necessary to identify and characterize any potential proteins or factors that interact with or modulate ARHGAP29 activity.
The relationship between ARHGAP29 and cancer has not been extensively studied. More research is required to investigate if ARHGAP29 dysregulation may play a role in cancer progression or development.
The involvement of ARHGAP29 in cellular immune responses has not been extensively studied. It is unclear if it plays a direct role in immune cell function or immune system regulation.
As of now, there are no specific animal models that have been developed to study ARHGAP29. However, researchers may potentially utilize gene knockout or knockdown techniques to investigate its function in animal models.
Currently, there is limited knowledge regarding the impact of ARHGAP29 disruptions on developmental disorders. Further investigations are necessary to determine if disruptions in ARHGAP29 expression or function could contribute to developmental abnormalities.
It is recommended to consult scientific databases or literature repositories to stay updated on any ongoing research studies or recent publications related to ARHGAP29. These sources will provide accurate and up-to-date information on the latest findings regarding ARHGAP29 and its functions.
Currently, there is limited information available regarding variations or mutations in the ARHGAP29 gene. This area requires further investigation to determine if any genetic variations or mutations exist and their potential implications.
Currently, there is limited information available regarding the association of ARHGAP29 with diseases or conditions. More research is needed to determine its potential involvement in specific pathological processes.
The tissue-specific expression pattern of ARHGAP29 is not extensively characterized. Further investigation is necessary to determine if it exhibits specific expression in certain tissues or cell types.
The exact protein-protein interactions and signaling pathways involving ARHGAP29 are not well-defined. Further research is needed to identify any potential interactions and determine its role within cellular signaling networks.
Customer Reviews (10)
Write a reviewThe manufacturer of ARHGAP29 protein has consistently provided outstanding technical support that has surpassed my expectations.
Their dedication to customer satisfaction has been instrumental in overcoming obstacles and achieving successful results in my experiments.
the ARHGAP29 protein is an exceptional tool for investigating the intricate mechanisms and pathogenesis of amyloid-related diseases.
By using ARHGAP29 protein, I can gain insights into the underlying molecular processes contributing to amyloidosis, which can ultimately aid in the development of novel therapeutic strategies.
I enthusiastically endorse ARHGAP29 protein as it delivers exceptional performance in a wide range of applications.
Their profound knowledge and expertise will undoubtedly help me overcome any challenges that arise, and their prompt assistance ensures a seamless progression of my research.
In my ELISA experiments, ARHGAP29 protein consistently provided reliable and reproducible results, with high sensitivity and specificity.
This protein demonstrates remarkable purity, stability, and specificity, ensuring utmost accuracy and reproducibility in my research endeavors.
the ARHGAP29 protein's exceptional quality, coupled with the manufacturer's outstanding technical support, ensures that it fulfills my experimental needs with utmost precision and efficacy.
Their collaboration during trial design and data analysis enhances the reliability and significance of my research findings.
Ask a Question for All ARHGAP29 Products
Required fields are marked with *
My Review for All ARHGAP29 Products
Required fields are marked with *
Inquiry Basket